Abstract
Background and objectives
Vitamin D deficiency causes muscle weakness, impairs bone formation and neuromuscular coordination thus leading to an increase in fracture risk. It has been found that inadequate levels of vitamin D are present in most of the osteoporosis patients. However, very few studies investigate the association between vitamin D status and quality of life (QOL). The aim of this study is to investigate the effects of vitamin D on QOL among Turkish women with osteoporosis.
Methods
259 patients (61.0 ± 8.9 years) with osteoporosis were evaluated by physical activity level, back pain, bone turnover markers, 25-hydroxyvitamin D [25(OH)D], parathyroid hormone levels and bone mineral density. QOL was assessed using QOL Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). 25(OH)D levels below 20 ng/ml was defined as vitamin D insufficiency, below 12 ng/ml as vitamin D deficiency.
Results
Mean 25(OH)D level was 22.7 ± 12.6 ng/ml and mean total QUALEFFO score was 43.3 ± 14.9. Vitamin D levels were significantly correlated with all subscales and total score of QUALEFFO (r = −0.25, P = 0.0001). Vitamin D insufficiency was determined in 132 patients (51%). In vitamin D deficient (<12 ng/ml) group all subscales and total QOL were found to be poorer when compared with the groups whose vitamin D levels were ≥12 and <20 ng/ml and ≥20 ng/ml (effect sizes 0.41 and 0.62 respectively, P = 0.0001 for total QOL). Vitamin D level, education, concomitant diseases, physical activity level and pain severity were found to be significantly associated with QOL in multiple linear regression analysis model.
Conclusions
Vitamin D insufficiency affects physical, social and mental functions of osteoporosis patients and impairs QOL. Vitamin D was found to be one of the factors affecting QOL.
Similar content being viewed by others
Abbreviations
- QOL:
-
Quality of life
- 25(OH)D:
-
25-Hydroxyvitamin D
- BMD:
-
Bone mineral density
- BMI:
-
Body mass index
- VAS:
-
Visual analogue scale
- PTH:
-
Parathyroid hormone
- SDI:
-
Spinal deformity index
- DEXA:
-
Dual energy X-Ray absorbtiometry
- QUALEFFO:
-
Quality of Life Questionnaire of the European Foundation for Osteoporosis
References
Geusens, P. (2003). Osteoporosis: Clinical features. In M. Hochberg, A. J. Silman, & J. S. Smolen (Eds.), Rheumatology (pp. 2081–92). Toronto: Mosby.
Francis, R. M. (2001). Falls and fractures. Age and Ageing, 30(Suppl 4), 25–28.
Lips, P., & van Schoor, N. M. (2005). Quality of life in patients with osteoporosis. Osteoporosis International, 16, 447–455.
Mosekilde, L. (2005). Vitamin D and the elderly. Clinical Endocrinology, 62, 265–281.
Reginster, J. Y. (2005). The high prevalence of inadequate serum vitamin D levels and implications for bone health. Current Medical Research and Opinion, 21(4), 579–585.
Zittermann, A. (2003). Vitamin D in preventive medicine: Are we ignoring the evidence? The British Journal of Nutrition, 89, 552–572.
Janssen, H. C. J. P., Samson, M. M., & Verhaar, H. J. J. (2002). Vitamin D deficiency, muscle function, and falls in elderly people. The American Journal of Clinical Nutrition, 75, 611–615.
Montero-Odasso, M., & Duque, G. (2005). Vitamin D in the aging musculoskeletal system: An authentic strength preserving hormone. Molecular Aspects of Medicine, 26, 203–219.
Dhesi, J. K., Jackson, S. H. D., Bearne, L. M., Moniz, C., Hurley, M. V., Swift, C. G., et al. (2004). Vitamin D supplementation improves neuromuscular function in older people who fall. Age and Ageing, 33, 589–595.
Di Monaco, M., Vallero, F., Di Monaco, R., Mautino, F., & Cavanna, A. (2005). Serum levels of 25-hydroxyvitamin D and functional recovery after hip fracture. Archives of Physical Medicine and Rehabilitation, 86, 64–68.
Chapuy, M. C., Preziosi, P., Maamer, M., Arnaud, S., Galan, P., Hercberg, S., et al. (1997). Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis International, 7, 439–443.
Sharla, S. H. (1998). Prevalence of subclinical vitamin D deficiency in different European countries. Osteoporosis International (Suppl 8), S7–S12.
Need, A. G., Horowitz, M., Morris, H. A., & Nordin, B. E. C. (2000). Vitamin D status: Effects on parathyroid hormone and 1,25-dihydroxyvitamin D in postmenopausal women. American Journal of Clinical Nutrition, 71, 1577–1581.
Hanley, D. A., & Davison, S. (2005). Vitamin D insufficiency in North America. Journal of Nutrition, 135, 332–337.
Pfeifer, M., Begerow, B., & Minne, H. W. (2002). Vitamin D and muscle function. Osteoporosis International, 13, 187–194.
Lips, P. (2004). Which circulating level of 25-hydroxyvitamin D appropriate? The Journal of Steroid Biochemistry and Molecular Biology, 89–90(1–5), 611–614.
Brown, J. P., Josse, R. G., & the Scientific Advisory Council of the Osteoporosis Society of Canada. (2002). 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ, 167(10 Suppl), S1–S34.
Genant, H. K., & Jergas, M. (2003). Assessment of prevalent and incident vertebral fractures in osteoporosis research. Osteoporosis International, 14(Suppl 3), S43–S55.
Crans, G. G., Genant, H. K., & Krege, J. H. (2005). Prognostic utility of a semiquantitative spinal deformity index. Bone, 37(2), 175–179.
Koçyiğit, H., Gülseren, Ş., Erol, A., Hizli, N., & Memis, A. (2003). The reliability and validity of the Turkish version of Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Clinical Rheumatology, 22, 18–23.
Lips, P., Cooper, C., Agnusdei, D., Caulin, F., Egger, P., Johnell, O., et al. (1999). Quality of life in patients with vertebral fractures: Validation of the quality of life questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Osteoporosis International, 10, 150–160.
Silverman, S. L. (2005). Quality-of-life issues in osteoporosis. Current Rheumatology Reports, 7(1), 39–45.
Kessenich, C. R., Guyatt, G. H., & Rosen, C. J. (1998). Health-related quality of life and participation in osteopororsis clinical trials. Calcified Tissue International, 62, 189–192.
Bianchi, M. L., Orsini, M. R., Saraifoger, S., Ortolani, S., Radaelli, G., & Betti, S. (2005). Quality of life in post-menopausal osteoporosis. Health and Quality of Life Outcomes, 3, 78. Retrieved May 1, 2006, from http://www.hqlo.com/content/3/1/78.
Holick, M. F., Siris, E. S., Binkley, N., Beard, M. K., Khan, A., Katzer, J. T., et al. (2005). Prevalance of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. Journal of Clinical Endocrinology Metabolism, 90, 3215–3224.
Gaugris, S., Heaney, R. P., Bonen, S., Kurth, H., Bentkover, J. D., & Sen, S. S. (2005). Vitamin D inadequacy among post-menopausal women: A systematic review. QJM, 98(9), 667–676.
Hollis, B. W. (2005). Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D. Journal of Nutrition, 135, 317–322.
Vieth, R., Cole D. E., Hawker, D. A., Trang, H. M., & Rubin, L. A. (2001). Wintertime Vitamin D insufficiency is common in young Canadian women and their vitamin D intake does not prevent it. European Journal of Clinical Nutrition, 55, 1091–1097.
Heaney, R. P., Davies, K. M., Chen, T. C., Holick, M. F., & Barger-Lux, M. J. (2003). Human serum 25-hydroxycholecalciferol response to extended dosing with cholecalciferol. American Journal of Clinical Nutrition, 77, 204–210.
Gerdheim, P., Ringsberg, K. A. M., Obrant, K. J., & Akesson, K. (2005). Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA study of elderly women. Osteoporosis International, 16, 1425–1431.
Di Monaco, M., Vallero, F., Di Monaco, R., Tappero, R., & Cavanna, A. (2006). 25-hydroxyvitamin D, parathyroid hormone, and functional recovery after hip fracture in elderly patients. Journal of Bone and Mineral Metabolism, 24, 42–47.
Porthouse, J., Cockayne, S., King, C., Saxon, L., Steele, E., Aspray, T., et al. (2005). Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ, 330, 1003–1007.
Harris, S., & Dawson-Hughes, B. (1993). Seasonal mood changes in 250 normal women. Psychiatry Research, 49(1), 77–87.
Gloth, F. M., Alam, W., & Hollis, B. (1999). Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. The Journal of Nutrition, Health and Aging, 3(1), 5–7.
Acknowledgement
We thank Gulsah Seydaoglu, MD, PhD for her valuable contribution with the statistical analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Basaran, S., Guzel, R., Coskun-Benlidayi, I. et al. Vitamin D status: effects on quality of life in osteoporosis among Turkish women. Qual Life Res 16, 1491–1499 (2007). https://doi.org/10.1007/s11136-007-9257-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-007-9257-6